InMed Pharmaceuticals Inc. (INM) Social Stream
INMED PHARMACEUTICALS INC (INM) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering INM.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 20 months, INM's average price target has gone up $33.5.
INM reports an average of 2,562.72% for its upside potential over the past 0 secs.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
INM Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
INM's average broker recommendation rating improved by 1 over the prior 35 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for INM as an investment opportunity.
- In terms of how INMED PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 22.54% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, INMED PHARMACEUTICALS INC's variance in analysts' estimates is lower than -98.86% of them.
- In terms of how INMED PHARMACEUTICALS INC fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1033.01% of that group.
- In the context of Pharmaceutical Products stocks, INMED PHARMACEUTICALS INC's average analyst price target is higher than 480.87% of them.
In the Pharmaceutical Products industry, PTPI, GRI, and LIPO are the three stocks most similar to INMED PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is INM a Buy, Hold or Sell? See the POWR Ratings now!